Adial Pharmaceuticals (ADIL) Short Interest Ratio & Short Volume → America could fall from this event (From Porter & Company) (Ad) Free ADIL Stock Alerts $1.46 +0.02 (+1.04%) (As of 09:37 AM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Adial Pharmaceuticals Short Interest DataCurrent Short Volume167,100 sharesPrevious Short Volume1,010,000 sharesChange Vs. Previous Month-83.46%Dollar Volume Sold Short$284,070.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares4,050,000 sharesFloat Size3,780,000 sharesShort Percent of Float4.42%Today's Trading Volume10,699 sharesAverage Trading Volume4,378,360 sharesToday's Volume Vs. Average0% Short Selling Adial Pharmaceuticals ? Sign up to receive the latest short interest report for Adial Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADIL Short Interest Over TimeADIL Days to Cover Over TimeADIL Percentage of Float Shorted Over Time Ad Porter & CompanyGuard Against the Coming Financial UpheavalAmerica’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. Adial Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024167,100 shares $284,070.00 -83.5%4.4%0 $1.70 4/15/20241,010,000 shares $2.64 million +11,509.2%26.7%0.2 $2.61 3/31/20248,700 shares $11,571.00 -91.8%0.2%0 $1.33 3/15/2024105,600 shares $166,848.00 +275.8%7.0%0 $1.58 2/29/202428,100 shares $57,324.00 -83.8%1.9%0 $2.04 2/15/2024173,300 shares $201,028.00 +691.3%11.5%0.6 $1.16 Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202421,900 shares $24,968.19 -41.1%1.5%0.2 $1.14 1/15/202437,200 shares $53,984.64 +11.4%2.6%0.4 $1.45 12/31/202333,400 shares $62,124.00 +29.5%3.2%0.3 $1.86 12/15/202325,800 shares $45,150.00 -37.4%2.4%0.3 $1.75 11/30/202341,200 shares $90,228.00 -22.3%3.9%0.6 $2.19 11/15/202353,000 shares $112,360.00 -1.5%5.0%1.2 $2.12 10/31/202353,800 shares $103,834.00 +93.5%5.1%0.8 $1.93 10/15/202327,800 shares $77,006.00 -45.3%2.6%0.4 $2.77 9/30/202350,800 shares $141,218.92 +49.4%4.8%0.3 $2.78 9/15/202334,000 shares $99,620.00 -47.4%3.3%0.3 $2.93 8/31/202364,600 shares $282,948.00 -12.6%6.2%0.5 $4.38 8/15/202373,900 shares $283,916.41 +121.3%7.1%0.6 $3.84 7/31/202333,400 shares $268,035.00 -97.7%N/A0.3 $8.03 7/15/20231,430,000 shares $395,538.00 +3,084.9%N/A0.6 $0.28 6/30/202344,900 shares $9,348.18 -24.3%N/A0 $0.21 6/15/202359,300 shares $14,528.50 -36.4%N/A0.3 $0.25 5/31/202393,200 shares $24,511.60 -71.3%N/A0.3 $0.26 5/15/2023324,800 shares $104,812.96 -22.0%N/A0.5 $0.32 4/30/2023416,400 shares $143,449.80 +42.6%N/A0.6 $0.34 4/15/2023292,100 shares $87,045.80 -12.0%N/A0.4 $0.30 3/31/2023332,000 shares $116,200.00 -38.8%N/A0.5 $0.35 3/15/2023542,700 shares $201,884.40 +42.2%N/A0.8 $0.37 2/28/2023381,600 shares $167,904.00 +37.9%N/A0.6 $0.44 2/15/2023276,700 shares $102,655.70 +105.9%N/A1.1 $0.37 1/31/2023134,400 shares $63,168.00 -7.0%N/A0.6 $0.47 1/15/2023144,500 shares $46,254.45 +12.3%N/A1 $0.32 12/30/2022128,700 shares $27,670.50 -4.0%N/A1 $0.22 12/15/2022134,100 shares $32,572.89 +4.0%N/A1.4 $0.24 11/30/2022128,900 shares $34,789.98 -3.9%N/A1.3 $0.27 11/15/2022134,100 shares $39,438.81 -9.4%N/A0.9 $0.29 10/31/2022148,000 shares $43,660.00 -8.0%N/A0.9 $0.30 10/15/2022160,900 shares $52,614.30 -8.0%N/A0.6 $0.33 9/30/2022174,900 shares $61,215.00 -28.9%N/A0.3 $0.35 9/15/2022246,000 shares $119,777.40 -26.8%N/A0.3 $0.49Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic ADIL Short Interest - Frequently Asked Questions What is Adial Pharmaceuticals' current short interest? Short interest is the volume of Adial Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 167,100 shares of ADIL short. 4.42% of Adial Pharmaceuticals' shares are currently sold short. Learn More on Adial Pharmaceuticals' current short interest. Which institutional investors are shorting Adial Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adial Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Adial Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.42% of Adial Pharmaceuticals' floating shares are currently sold short. Is Adial Pharmaceuticals' short interest increasing or decreasing? Adial Pharmaceuticals saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 167,100 shares, a decline of 83.5% from the previous total of 1,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adial Pharmaceuticals' float size? Adial Pharmaceuticals currently has issued a total of 4,050,000 shares. Some of Adial Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adial Pharmaceuticals currently has a public float of 3,780,000 shares. How does Adial Pharmaceuticals' short interest compare to its competitors? 4.42% of Adial Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Adial Pharmaceuticals: Lixte Biotechnology Holdings, Inc. (1.31%), Oragenics, Inc. (2.07%), Kintara Therapeutics, Inc. (10.35%), Enveric Biosciences, Inc. (1.07%), Xenetic Biosciences Inc (0.50%), Kineta, Inc. (1.96%), Hoth Therapeutics, Inc. (2.73%), Ainos, Inc. (2.12%), ASLAN Pharmaceuticals Limited (4.12%), Pulmatrix, Inc. (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Adial Pharmaceuticals stock? Short selling ADIL is an investing strategy that aims to generate trading profit from Adial Pharmaceuticals as its price is falling. ADIL shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adial Pharmaceuticals? A short squeeze for Adial Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADIL, which in turn drives the price of the stock up even further. How often is Adial Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADIL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: LIXT Short Interest Data OGEN Short Interest Data KTRA Short Interest Data ENVB Short Interest Data XBIO Short Interest Data KA Short Interest Data HOTH Short Interest Data AIMD Short Interest Data ASLN Short Interest Data PULM Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADIL) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsElon’s New Device is About to Shock the WorldInvestorPlaceWhat’s Really Next for America…Porter & CompanyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press